Transdermal absorption testing is a critical evaluation for Traditional Chinese Medicine (TCM) topical formulations, quantifying how active herbal components permeate the skin barrier to reach systemic circulation or local target tissues. This technical article explains the testing principles, sample types, measured parameters, laboratory methods, and practical applications of percutaneous absorption studies for TCM plasters, ointments, gels, and liniments.
Technical Overview
Traditional Chinese Medicine transdermal absorption testing evaluates the ability of pharmacologically active components in externally applied herbal preparations to cross the stratum corneum, diffuse through the viable epidermis and dermis, and enter the receptor medium or bloodstream. Because TCM external formulations—such as gel plasters, medicated patches, ointments, and liniments—deliver therapeutic effects through percutaneous penetration, demonstrating and quantifying absorption behavior is essential for formulation development, quality control, and regulatory documentation.
The core experimental platform for this evaluation is the in vitro diffusion cell system, most commonly the vertical Franz diffusion cell. A piece of excised skin is mounted between a donor compartment containing the test formulation and a receptor compartment filled with receptor medium maintained at a physiologically relevant temperature. At predetermined time points, receptor fluid is sampled and analyzed by chromatographic techniques such as HPLC, UPLC, or LC-MS/MS to construct permeation profiles and calculate kinetic parameters.
Compared with single-entity chemical drugs, TCM formulations present unique analytical challenges: they contain multiple active markers, complex matrix systems, and volatile or thermally labile constituents. A scientifically designed transdermal absorption study must therefore address marker selection, skin model suitability, sink conditions, and method validation simultaneously to produce reproducible, submission-ready data.
Testing Samples
Gel Plasters and Medicated Patches
Gel plasters (hydrogel-based cataplasms) and adhesive patches are among the most common TCM transdermal dosage forms. Testing focuses on both drug release from the matrix and percutaneous permeation through excised skin, since the patch matrix, pressure-sensitive adhesive, and backing membrane all influence delivery. Studies typically compare cumulative permeation across formulation variants to optimize gel base composition, loading, and adhesive properties.
Ointments, Creams, and Gels
Semi-solid preparations such as ointments, creams, and topical gels are evaluated for release and permeation behavior differences driven by base type, viscosity, and particle size of herbal extracts. Water-soluble gel bases and oleaginous ointment bases produce distinct diffusion kinetics, and side-by-side comparison guides formulation selection.
Liniments, Spirits, and Medicated Oils
Liquid external preparations containing volatile constituents, tinctures, and herbal-infused oils are tested to assess rapid permeation characteristics. For volatile markers such as menthol, borneol, and essential oil components, sealed donor compartments and appropriate analytical detection are required to prevent evaporative loss and ensure accurate quantification.
Herbal Extracts and Penetration Enhancer Systems
Purified TCM extracts, fractionated components, and penetration enhancer candidates are screened early in development. Classic enhancers used in TCM—including borneol, menthol, and synthetic agents such as Azone—are characterized by their effect on steady-state flux and skin retention of co-administered marker compounds.
Reference Substances and Placebo Matrices
Chemical reference standards of marker constituents (for example, paeoniflorin, icariin, geniposide, ferulic acid, or tetramethylpyrazine) are required for calibration, while blank matrices without active ingredient serve as controls to verify method specificity and exclude matrix interference.
Testing Items
A complete transdermal absorption study reports the following quantitative parameters derived from the permeation profile:
- Cumulative permeation amount (Q): the total quantity of each marker compound that has permeated per unit skin area (µg/cm²) at each sampling time point, plotted as a Q–t or Q–√t profile.
- Steady-state flux (Jss): the slope of the linear portion of the cumulative permeation curve, expressed in µg/(cm²·h), representing the constant percutaneous absorption rate.
- Permeability coefficient (Kp): the apparent permeability calculated as Jss divided by donor concentration (cm/h or cm/s), used to compare intrinsic skin transport across formulations.
- Lag time (Tlag): the x-intercept of the steady-state line, reflecting the time required for the drug to saturate the skin membrane before linear diffusion is established.
- Skin retention amount: the quantity of marker remaining within the skin tissue at the end of the experiment, which is particularly relevant for locally acting TCM preparations intended to treat musculoskeletal or dermatological conditions.
- Enhancement ratio: the fold-increase in Jss achieved by a penetration enhancer or optimized matrix relative to a reference formulation.
- Permeation kinetics fitting: regression of the permeation data against zero-order, first-order, Higuchi, and other kinetic models to characterize the dominant release and diffusion mechanism.
- Mass balance: accounting for donor residue, skin content, and receptor content to verify experimental integrity.
Testing Methods
In Vitro Franz Diffusion Cell Method
The vertical Franz diffusion cell is the standard platform. Excised skin is mounted with the stratum corneum facing the donor compartment, and the test formulation is applied at a defined dose. The receptor compartment, typically 5–20 mL in volume, is filled with degassed receptor medium and stirred magnetically at a constant rate. The chamber is thermostatically maintained at 32 ± 1°C to simulate skin surface temperature. Receptor samples are withdrawn at predetermined intervals (commonly 0.5, 1, 2, 4, 6, 8, 12, and 24 hours) with immediate volume replacement, and the collected samples are analyzed chromatographically.
Skin Membrane Selection and Preparation
Common membrane models include:
- Excised rodent skin (rat or mouse abdomen skin): widely used due to availability, although generally more permeable than human skin.
- Porcine ear skin: histologically and permeability-wise close to human skin, and an increasingly preferred model.
- Snake shed skin: useful as a stratum corneum model for lipophilic compounds.
- Human cadaver or surgically excised skin: the gold standard where ethically and logistically available.
- Artificial membranes: used for in vitro release testing to separate release kinetics from permeation.
Skin integrity is verified before dosing by visual inspection, transepidermal water loss (TEWL), or electrical resistance measurement, and subcutaneous fat is carefully trimmed without damaging the dermal barrier.
Receptor Medium and Sink Conditions
The receptor medium must maintain sink conditions and membrane viability. Phosphate-buffered saline (pH 7.4), normal saline, and Ringer solution are used for hydrophilic markers, while hydroalcoholic mixtures (20–40% ethanol) or media containing low concentrations of surfactant (such as sodium lauryl sulfate or Tween 80) are employed for poorly water-soluble TCM constituents. The medium must be validated not to damage the skin barrier during the study period.
Analytical Quantification
Receptor samples are quantified using validated HPLC-UV, HPLC-ELSD, UPLC, LC-MS/MS, or GC-MS methods depending on the physicochemical properties of the marker compounds. Method validation covers specificity against blank skin extract, linearity, precision, accuracy, recovery, lower limit of quantification, and sample stability. For multi-component TCM systems, several representative markers are monitored simultaneously to characterize overall absorption behavior.
In Vivo Percutaneous Absorption Methods
Where systemic exposure data are required, in vivo approaches complement the in vitro study: dermal microdialysis continuously samples interstitial fluid beneath the application site, tape stripping quantifies drug within stratum corneum layers, and plasma pharmacokinetic sampling following topical administration to laboratory animals defines systemic bioavailability. In vitro–in vivo correlation (IVIVC) analysis links flux data to observed exposure.
Applications
- Formulation screening and optimization: comparing gel bases, adhesives, solvent systems, and herbal loading levels to maximize flux of key markers.
- Penetration enhancer evaluation: quantifying enhancement ratios for borneol, menthol, volatile oils, Azone, and other enhancers commonly paired with TCM extracts.
- Dosage form comparison: demonstrating equivalence or superiority between patches, ointments, gels, and liniments during product development.
- Quality-by-design and CMC documentation: establishing permeation performance as a critical quality attribute supporting batch consistency and manufacturing changes.
- Safety assessment: estimating systemic exposure from topical use, supporting margin-of-safety calculations for potent or toxic herbal constituents.
- Regulatory submission support: generating permeation data packages for registration dossiers of TCM external preparations in accordance with pharmacopoeial and ICH-aligned expectations.
- Drug–device combination research: evaluating microneedle, iontophoresis, and ultrasound-assisted delivery strategies for enhancing TCM percutaneous absorption.
FAQ
Q: Which skin model should be chosen for a TCM transdermal study?
A: Porcine ear skin offers the best balance of human relevance and availability for most studies, while excised rat skin is acceptable for formulation comparison due to its higher throughput. Human skin is recommended when the study is intended to support predictive human exposure estimates. The choice should be justified by the lipophilicity and permeability of the selected markers.
Q: How long should the permeation experiment run?
A: A standard study runs 24 hours with sampling up to that endpoint; 48-hour designs are used for sustained-release patches or highly lipophilic constituents with long lag times. Skin integrity is re-checked at the end of the run to confirm the barrier remained valid throughout.
Q: How are multi-component TCM systems handled analytically?
A: A small set of representative, chemically defined marker compounds is selected based on pharmacological relevance, adequate content, and analytical detectability. LC-MS/MS enables simultaneous multi-marker quantification even when individual permeated amounts are low.
Q: Why is skin retention measured in addition to receptor permeation?
A: Many TCM external preparations act locally on muscles, joints, or skin. The drug retained within skin tissue forms a local reservoir and may correlate better with local efficacy than receptor flux, so both parameters are reported.
Q: Are in vitro flux results predictive of human absorption?
A: Properly designed studies using human or porcine skin under validated sink conditions provide good rank-order prediction of relative human absorption. Absolute prediction improves when in vitro data are corroborated by in vivo pharmacokinetic or microdialysis results, and species differences in skin permeability are taken into account.